Barely Significant
← all excerpts

Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma.

Pharmaceutics · 2025 · PMC12030150 · PMID 40284530

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp ≤ 0.001actually significant
Statistical analysis of cell migration rates revealed a highly significant difference between the treatment groups (TQ, DX, TQ + DX) and the control group ( p ≤ 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.